Completed Infection & Immunity Cells, Biochemistry & Physiology
The development of in silico designed human monoclonal antibodies for use in snake anti-venoms
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by InnovateUK.
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Generation of venom-neutralising recombinant chimeric antibodies
Progressing existing snake venom toxin-specific antibodies into humanised, thermostable monoclonal therapies for preclinical manufacture and clinical trials in Africa and India
Recombinant snakebite antivenom for sub-Saharan Africa
Antibody Discovery and Development Against Non-Immunogenic Snake Venom Toxins
Utilising snake endogenous toxin inhibitors for the development of improved antivenom treatments
Original classification
Fast TrackPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know